Literature DB >> 22302482

Involvement of heme oxygenase-1 in Korean colon cancer.

Kyoung Ah Kang1, Young Hee Maeng, Rui Zhang, Young Ro Yang, Mei Jing Piao, Ki Cheon Kim, Gi Young Kim, Young Ree Kim, Young Sang Koh, Hee Kyoung Kang, Chang Lim Hyun, Weon Young Chang, Jin Won Hyun.   

Abstract

Heme oxygenase-1 (HO-1) catabolizes heme into carbon monoxide, biliverdin, and free iron which mediate its protective effect against oxidative stress. The aim of the present study was to determine the expression level and activity of HO-1 in Korean colon cancer tissues and cell lines. HO-1 protein expression was higher (>1.5-fold) in tumor tissues than in adjacent normal tissues in 14 of 20 colon cancer patients, and HO-1 protein expression was closely correlated with HO-1 enzyme activity in cancer tissues. Immunohistochemical data confirmed that HO-1 protein was expressed at a higher level in colon cancer tissues than in normal mucosa. Furthermore, HO-1 mRNA and protein expression and enzyme activity were higher in the colon cancer cell lines Caco-2, SNU-407, SNU-1033, HT-29, and SW-403 than in the normal fetal human colon cell line FHC. Treatment with the HO-1 inhibitor zinc protoporphyrin decreased the viability of colon cancer cell lines. These data indicate that HO-1 may serve as a clinically useful biomarker of colon cancer and as a target for anticolon cancer drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302482     DOI: 10.1007/s13277-012-0336-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  34 in total

Review 1.  Heme oxygenase-1 in tumor biology and therapy.

Authors:  Halina Was; Jozef Dulak; Alicja Jozkowicz
Journal:  Curr Drug Targets       Date:  2010-12       Impact factor: 3.465

2.  Involvement of the heme oxygenase-carbon monoxide pathway in keratinocyte proliferation.

Authors:  J E Clark; C J Green; R Motterlini
Journal:  Biochem Biophys Res Commun       Date:  1997-12-18       Impact factor: 3.575

3.  Cytotoxic effects of flavonoids against a human colon cancer derived cell line, COLO 201: a potential natural anti-cancer substance.

Authors:  Masahiko Imai; Hidetomo Kikuchi; Takanori Denda; Kunio Ohyama; Chieko Hirobe; Hiroo Toyoda
Journal:  Cancer Lett       Date:  2008-12-12       Impact factor: 8.679

Review 4.  Heme oxygenase-1 in tumors: is it a false friend?

Authors:  Alicja Jozkowicz; Halina Was; Jozef Dulak
Journal:  Antioxid Redox Signal       Date:  2007-12       Impact factor: 8.401

Review 5.  Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment.

Authors:  J Fang; T Akaike; H Maeda
Journal:  Apoptosis       Date:  2004-01       Impact factor: 4.677

Review 6.  Review on meat consumption and cancer in South America.

Authors:  Elena Matos; Aldo Brandani
Journal:  Mutat Res       Date:  2002-09-30       Impact factor: 2.433

7.  Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia.

Authors:  Matthias Mayerhofer; Stefan Florian; Maria-Theresa Krauth; Karl J Aichberger; Martin Bilban; Rodrig Marculescu; Dieter Printz; Gerhard Fritsch; Oswald Wagner; Edgar Selzer; Wolfgang R Sperr; Peter Valent; Christian Sillaber
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

8.  Induction by prostaglandin A1 of haem oxygenase in myoblastic cells: an effect independent of expression of the 70 kDa heat shock protein.

Authors:  A Rossi; M G Santoro
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

9.  Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells.

Authors:  Zhi-Min Liu; George G Chen; Enders K W Ng; Wai-Keung Leung; Joseph J Y Sung; S C Sydney Chung
Journal:  Oncogene       Date:  2004-01-15       Impact factor: 9.867

10.  Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo.

Authors:  Philipp Nuhn; Beat M Künzli; René Hennig; Tomas Mitkus; Tadas Ramanauskas; Rainer Nobiling; Stefan C Meuer; Helmut Friess; Pascal O Berberat
Journal:  Mol Cancer       Date:  2009-06-09       Impact factor: 27.401

View more
  7 in total

1.  High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells.

Authors:  Z Zhao; Y Xu; J Lu; J Xue; P Liu
Journal:  Clin Transl Oncol       Date:  2017-08-14       Impact factor: 3.405

2.  Glucose-regulated protein 78 (GRP78) regulates colon cancer metastasis through EMT biomarkers and the NRF-2/HO-1 pathway.

Authors:  Yu-Jia Chang; Wei-Yu Chen; Chien-Yu Huang; Hui-Hsiung Liu; Po-Li Wei
Journal:  Tumour Biol       Date:  2014-11-28

3.  Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation.

Authors:  Gabor Oláh; Katalin Módis; Gabor Törö; Mark R Hellmich; Bartosz Szczesny; Csaba Szabo
Journal:  Biochem Pharmacol       Date:  2017-10-23       Impact factor: 5.858

4.  Radical decisions in cancer: redox control of cell growth and death.

Authors:  Rosa M Sainz; Felipe Lombo; Juan C Mayo
Journal:  Cancers (Basel)       Date:  2012-04-25       Impact factor: 6.639

5.  Heme oxygenase-1 promotes tumor progression and metastasis of colorectal carcinoma cells by inhibiting antitumor immunity.

Authors:  Geom Seog Seo; Wen-Yi Jiang; Jin Hua Chi; Hao Jin; Won-Chul Park; Dong Hwan Sohn; Pil-Hoon Park; Sung Hee Lee
Journal:  Oncotarget       Date:  2015-08-14

6.  Extracts from Sageretia thea reduce cell viability through inducing cyclin D1 proteasomal degradation and HO-1 expression in human colorectal cancer cells.

Authors:  Ha Na Kim; Gwang Hun Park; Su Bin Park; Jeong Dong Kim; Hyun Ji Eo; Ho-Jun Son; Jeong Ho Song; Jin Boo Jeong
Journal:  BMC Complement Altern Med       Date:  2019-02-08       Impact factor: 3.659

7.  Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation.

Authors:  K A Kang; M J Piao; K C Kim; H K Kang; W Y Chang; I C Park; Y S Keum; Y J Surh; J W Hyun
Journal:  Cell Death Dis       Date:  2014-04-17       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.